AstraZeneca - GBPAstraZeneca - GBPAstraZeneca - GBP

AstraZeneca - GBP

No trades
See on Supercharts

Key facts today


AstraZeneca's Trixeo Aerosphere inhaler for COPD has received UK approval, confirming its safety and effectiveness. It will be available in the UK in late 2025.
Analyze the impactAnalyze the impact

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.